Leukemia Vaccine Passes Key Trial Amid Breakthrough Year For Cancer Drugs
"A first-of-its-kind vaccine for acute myeloid leukemia, a deadly blood cancer, succeeded in a Phase 3 clinical trial, drugmaker Sellas Life Sciences and Memorial Sloan Kettering Cancer Center announced Tuesday, marking another positive result in a breakthrough year for cancer vaccines."











